In a recent article by Reuters, IPOX® Associate Lukas Muehlbauer offered his analysis on the market debut of firearms retailer GrabAGun (PEW). Muehlbauer comments on the company's decision to go public via a SPAC merger, noting, "The company's polarizing brand likely led it to choose a SPAC merger over a traditional IPO, exposing it to the market's skepticism."

In a Reuters article covering McGraw Hill's planned $4.2 billion IPO, IPOX® Vice President Kat Liu provided insight into the current market. She noted that the IPO window "feels more tactical than structural," prompting private equity sponsors to accelerate listing timelines "to get ahead of potential volatility" and secure liquidity while the opportunity is available.

IPOX® Research Associate Dr. Lukas Muehlbauer commented on key trends in European IPOs for Bloomberg, noting the best listings have been growth stories where proceeds are reinvested into the company, rather than deals where private equity owners cash out. Muehlbauer added that companies listing in the Nordic region and recent smaller listings have been the primary beneficiaries.

The global IPO market is seeing a surge of activity across the U.S., Asia, and MENA regions. Key highlights include crypto firm ReserveOne targeting a $1 billion+ Nasdaq listing and coffee chain Joe & The Juice exploring a $2.4 billion U.S. IPO. In the MENA region, Dubai Airports is eyeing a potential $1.5 billion offering. Significant listings are also underway for Korean shipbuilder Daehan and AI startup Zhipu, signaling broad investor appetite.

In a Bloomberg feature on private equity-backed companies returning to the public markets, IPOX® Founder Josef Schuster provided key insights. He explained that these offerings are "usually more efficiently priced than other IPOs, so we don’t expect to see a significant pop initially," despite a wide-open IPO window.

In a new report, Zacks Investment Research highlights two IPOX®-based ETFs (FPX, FPXI) as prime ways to access the recovering IPO market. Citing a sharp rebound in new listings and strong investor sentiment, the analysis points to significant growth opportunities. Our flagship U.S. and International indexes provide the basis for these featured funds.

The global IPO market shows renewed activity, led by major U.S. filings from tech firms like Figma, which is targeting a $1.5B offering, and chip designer Ambiq. In Asia, Apple supplier Luxshare is planning a Hong Kong listing to raise over $1B, while Saudi delivery firm Ninja hits a $1.5B valuation.

In a Reuters article on Ambiq Micro's U.S. IPO filing, IPOX® Research Associate Lukas Muehlbauer provided analysis on the company’s plans. He noted the chip designer's customer concentration risk but also highlighted its competitive advantage in the wearables market by targeting the "AI at the edge" niche with its ultra-low-power chips.

In a recent Bloomberg article, IPOX® Research Associate Lukas Muehlbauer commented on the significant rights issuance planned by Saudi Arabia's ACWA Power Co. The utility company is set to undertake the Middle East's largest such deal since 2023, aiming to raise $1.9 billion to fund its strategic expansion.

Market activity surges across the globe with several blockbuster listings on the horizon. In a major win for the London Stock Exchange, Norwegian software giant Visma is ditching Amsterdam to line up a €19 billion IPO in London. Meanwhile, the Asian markets are buzzing as fashion behemoth Shein prepares a landmark confidential filing in Hong Kong, a move expected to revitalize the city's capital markets. The U.S. also saw significant momentum, with travel tech firm Navan, previously valued at $9.2 billion, confidentially filing for its public debut.

In a Reuters article covering the strong market debut of Jefferson Capital, IPOX® Research Associate Lukas Muehlbauer provided commentary on the recovering U.S. IPO market. He noted the rebound is likely to be selective, "led by high-quality and long-anticipated issuers." Muehlbauer explained that an initial trading "pop" is part of the market's "healthy process of price discovery" to establish a sustainable price. Read more in the full article on the IPOX website.

In a recent Bloomberg article, IPOX® Research Associate Lukas Muehlbauer commented on the challenging European IPO market. Highlighting the recent withdrawal of several listings, Muehlbauer noted that investor appetite is particularly low for private equity exits where proceeds do not benefit the company. He stated, “Deals that are essentially existing owners cashing out are proving to be a tough sell.” Read more about his analysis of the current market sentiment on our blog.

The IPOX® 100 U.S. Index (ETF: FPX) is opening at a new all-time high, extending its year-to-date gain to +21%. This surge is driven by positive market sentiment, end-of-quarter positioning, and reassuring inflation comments from the FED. Other key indexes, including the IPOX® International (FPXI) and IPOX® 100 Europe (FPXE), also closed at multi-year highs, reflecting broad strength across the IPOX® portfolio and its position as the gold standard for IPOs.